NCT02779868View on ClinicalTrials.gov

Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Sarcopenia
Interventions
DIETARY_SUPPLEMENT

Omega-3

patients included in this group will take 2g (4 capsules) per day of eicosapentaenoic acid.

DIETARY_SUPPLEMENT

Olive oil

patients included in this group will take 4 capsules per day of olive oil.

Trial Locations (1)

20220-410

Brazilian National Cancer Institute, Rio de Janeiro

All Listed Sponsors
lead

Brazilian National Cancer Institute

OTHER_GOV

NCT02779868 - Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy | Biotech Hunter | Biotech Hunter